US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immuneering Corp

1.38

+0.11008.66%

Volume:120.65K

Turnover:161.26K

Market Cap:49.52M

PE:-0.68

High:1.39

Open:1.29

Low:1.26

Close:1.27

Loading ...

Overview Company News Filings

Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Immuneering Leads The Pack Of 3 US Penny Stocks To Consider

Simply Wall St.

Morgan Stanley Sticks to Their Sell Rating for Immuneering (IMRX)

Immuneering Price Target Maintained With a $15.00/Share by Needham

Promising Advancements and Investor Confidence Boost Buy Rating for Immuneering’s PDAC Therapy

Immuneering Corp - Initiation of Phase 2a Arms With Braf and Checkpoint Inhibitors Planned for 2025

THOMSON REUTERS

Immuneering Corp - Further Imm-1-104 Phase 2a Data Expected in Q2 2025

THOMSON REUTERS

Immuneering Provides Positive Update on Phase 2a Arm Studying Imm-1-104 in Combination With Modified Folfirinox for First-Line Pancreatic Cancer

THOMSON REUTERS

Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer

Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)

3 Penny Stocks to Watch Now, 1/9/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires Live

Immuneering Price Target Maintained With a $15.00/Share by Needham

Immuneering Shares up 50% After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy

THOMSON REUTERS

Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates

MT Newswires Live

BUZZ-Immuneering soars on positive trial data for pancreatic cancer therapy

Immuneering Shares up 51.7% Premarket After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy

THOMSON REUTERS

BRIEF-Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms Of Ongoing Phase 2A Trial Of IMM-1-104

Immuneering announce data update from Phase 2a trial of IMM-1-104

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IMRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":1.38,"timestamp":1745265600000,"preClose":1.27,"halted":0,"volume":120646,"delay":0,"floatShares":27234408,"shares":35887252,"eps":-2.035804,"marketStatus":"Pre-Mkt","change":0.11,"latestTime":"04-22 07:14:41 EDT","open":1.29,"high":1.39,"low":1.255,"amount":161256.1565,"amplitude":0.106299,"askPrice":1.49,"askSize":100,"bidPrice":1.37,"bidSize":313,"shortable":3,"etf":0,"ttmEps":-2.035804,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":1.38,"postHourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.38,"latestTime":"16:28 EDT","volume":113,"amount":155.94,"timestamp":1745267296646},"volumeRatio":1.0729219830701953},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","floatShares":27234408,"roa":"-51.57%","roe":"-92.51%","lyrEps":-2.035804,"volumeRatio":1.0729219830701953,"shares":35887252,"dividePrice":0,"high":1.39,"amplitude":0.106299,"preClose":1.27,"low":1.255,"week52Low":1,"pbRate":"1.20","psRate":"108844.85","week52High":3.83,"institutionHeld":0,"latestPrice":1.38,"committee":0.515738,"eps":-2.035804,"divideRate":0,"volume":120646,"delay":0,"ttmEps":-2.035804,"open":1.29,"prevYearClose":2.2,"prevWeekClose":1.27,"prevMonthClose":1.52,"prevQuarterClose":1.52,"fiveDayClose":1.29,"twentyDayClose":1.8,"sixtyDayClose":2.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508789601","title":"Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2508789601","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508789601?lang=en_us&edition=fundamental","pubTime":"2025-02-04 05:05","pubTimestamp":1738616700,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Feb.  03, 2025  (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/03/3019861/0/en/Immuneering-to-Present-at-the-Oppenheimer-35th-Annual-Healthcare-Life-Sciences-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPY","HCSG","BK4563","BK4539","IMRX","BK4137","BK4139","BK4127"],"gpt_icon":0},{"id":"2505875013","title":"Immuneering Leads The Pack Of 3 US Penny Stocks To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2505875013","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505875013?lang=en_us&edition=fundamental","pubTime":"2025-01-23 21:07","pubTimestamp":1737637629,"startTime":"0","endTime":"0","summary":"As the S&P 500 nears record highs, fueled by a surge in AI stocks and robust earnings reports, investors are keenly observing opportunities across various market segments. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.Overview: Immuneering Corporation is a clinical-stage oncology company focused on developing medicines for broad populations of cancer patients, with a market cap of $65.83 million.Immuneering Corporation, with a market cap of US$65.83 million, remains pre-revenue as it advances its clinical-stage oncology endeavors. The company is debt-free and has experienced management and board teams but faces challenges with less than a year of cash runway. Recent updates from Phase 2a trials showed promising results in pancreatic cancer treatments","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immuneering-leads-pack-3-us-130709797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IMRX","BK4539","BABB","PXLW","BK4209","BK4563"],"gpt_icon":0},{"id":"2503553842","title":"Morgan Stanley Sticks to Their Sell Rating for Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503553842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503553842?lang=en_us&edition=fundamental","pubTime":"2025-01-14 04:38","pubTimestamp":1736800707,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Jeffrey Hung maintained a Sell rating on Immuneering (IMRX – Research Report) today. The company’s shares opened today at $2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-sell-rating-for-immuneering-imrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-their-sell-rating-for-immuneering-imrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX"],"gpt_icon":0},{"id":"2503582035","title":"Immuneering Price Target Maintained With a $15.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2503582035","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503582035?lang=en_us&edition=fundamental","pubTime":"2025-01-14 00:19","pubTimestamp":1736785140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2025 11:19 ET (16:19 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX"],"gpt_icon":0},{"id":"2503584514","title":"Promising Advancements and Investor Confidence Boost Buy Rating for Immuneering’s PDAC Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2503584514","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503584514?lang=en_us&edition=fundamental","pubTime":"2025-01-13 23:45","pubTimestamp":1736783116,"startTime":"0","endTime":"0","summary":"Needham analyst Ami Fadia maintained a Buy rating on Immuneering (IMRX – Research Report) today and set a price target of $15.00. Ami Fadia’s ratin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-advancements-and-investor-confidence-boost-buy-rating-for-immuneerings-pdac-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-advancements-and-investor-confidence-boost-buy-rating-for-immuneerings-pdac-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX"],"gpt_icon":0},{"id":"2503309694","title":"Immuneering Corp - Initiation of Phase 2a Arms With Braf and Checkpoint Inhibitors Planned for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309694","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309694?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA1ZTH6B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IMRX","BK4563","BK4539"],"gpt_icon":0},{"id":"2503309642","title":"Immuneering Corp - Further Imm-1-104 Phase 2a Data Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309642?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA1ZTH6B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2503309560","title":"Immuneering Provides Positive Update on Phase 2a Arm Studying Imm-1-104 in Combination With Modified Folfirinox for First-Line Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309560?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA1ZTH6B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2503309430","title":"Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309430","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309430?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"- Two new partial responses (PRs) reported in Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX (mFFX) in first-line pancreatic cancer - - Overall Response Rate (ORR) of 50%; his","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/13/3008480/0/en/Immuneering-Provides-Positive-Update-on-Phase-2a-Arm-Studying-IMM-1-104-in-Combination-with-Modified-FOLFIRINOX-for-First-Line-Pancreatic-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BMPRXN33.USD","BK4543","BK4563","BK4588","BK4141","IMRX","BK4139","LU0348723411.USD","IE00BMPRXQ63.HKD","BK4539","IE00BMPRXR70.SGD"],"gpt_icon":1},{"id":"2502369363","title":"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502369363","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502369363?lang=en_us&edition=fundamental","pubTime":"2025-01-12 18:40","pubTimestamp":1736678417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immuneering (IMRX – Research Report) and Johnson & J...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2347655156.SGD","BK4563","JNJ","LU1914381329.SGD","BK4137","LU1778281490.HKD","IE0002270589.USD","LU0912757837.SGD","LU1066051225.USD","LU1261432733.SGD","LU1059921491.USD","LU1732799900.SGD","BK4592","IE00B2B36J28.USD","LU0058720904.USD","LU2468319806.SGD","LU1066051498.USD","IE00BDGV0183.EUR","LU0320765646.SGD","LU1162221912.USD","IE00BVYPNW00.USD","HCSG","LU1244550577.SGD","IE0034235303.USD","LU0122379950.USD","LU1221951129.SGD","LU1718418525.SGD","LU0882574055.USD","LU2602419157.SGD","IE00B19Z3581.USD","LU1894683348.USD","IE00B7SZLL34.SGD","IE00BGHQF631.EUR","BK4585","LU1935042991.SGD","IE00BVYPNV92.GBP","IE00B42XCP33.USD","LU2133065610.SGD","LU1585245621.USD","BK4504","IMRX","LU1196500208.SGD","LU1929549753.HKD","LU0466842654.USD","BK4532","BK4588","LU1066053197.SGD","LU0234570918.USD","IE00BJJMRZ35.SGD","BK4559"],"gpt_icon":0},{"id":"2502099983","title":"3 Penny Stocks to Watch Now, 1/9/25","url":"https://stock-news.laohu8.com/highlight/detail?id=2502099983","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502099983?lang=en_us&edition=fundamental","pubTime":"2025-01-09 17:42","pubTimestamp":1736415747,"startTime":"0","endTime":"0","summary":"Hoth Therapeutics, XTI Aerospace, and Immuneering are the 3 Penny Stocks to watch on January 9, 2025, based on TipRanks’ Penny Stock...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-1-9-25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-1-9-25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX","BK4563","BK4539","BK4139"],"gpt_icon":0},{"id":"2501742689","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501742689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501742689?lang=en_us&edition=fundamental","pubTime":"2025-01-08 18:50","pubTimestamp":1736333450,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sana Biotechnology (SANA – Research Report), Immun...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0466842654.USD","IMRX","LU1196500208.SGD","IE00B7SZLL34.SGD","LU1023059063.AUD","LU0058720904.USD","SANA","IE0002141913.USD","LU1221951046.USD","LU1267930813.SGD","LU1929549753.HKD","LU0114720955.EUR","LU1914381329.SGD","SG9999002224.SGD","LU0122379950.USD","BK4007","IE00B1BXHZ80.USD","LU1074936037.SGD","LU1585245621.USD","LU1066051225.USD","LU0234570918.USD","BK4585","BK4568","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1430594728.SGD","LU1674673428.USD","LU1066051498.USD","LU1244550221.USD","LU1732799900.SGD","LU1935042991.SGD","IE00BJT1NW94.SGD","BK4532","LU0912757837.SGD","LU1066051811.HKD","LU0792757196.USD","LU1280957306.USD","LU0640476718.USD","LU0203345920.USD","LU0889566641.SGD","LU1221951129.SGD","LU2602419157.SGD","LU1778281490.HKD","LU1261432733.SGD","IE00BDGV0183.EUR","JNJ","LU1732800096.USD","LU2468319806.SGD","HCSG","BK4504"],"gpt_icon":0},{"id":"2501362947","title":"Sector Update: Health Care Stocks Rise in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2501362947","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501362947?lang=en_us&edition=fundamental","pubTime":"2025-01-08 02:58","pubTimestamp":1736276322,"startTime":"0","endTime":"0","summary":"Health care stocks rose Tuesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both up 0.7%.The iShares Biotechnology ETF (IBB) climbed 1.2%.In corporate n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GB00B4LPDJ14.GBP","BK4082","LU0114720955.EUR","SYK","XLV","GB00B4QBRK32.GBP","BK4563","LU0390134368.USD","BK4588","LU1791710400.SGD","LU1983299246.USD","BK4007","BK4539","LU2468319806.SGD","LU0690374615.EUR","BK4585","LU1791710582.SGD","BK4504","LU2404859667.USD","BK4581","LU2362541513.USD","IMRX","HOTH","BK4566","NARI","LU0528227936.USD","BK4139","LU2404859741.USD","LU2362541273.HKD","LU0690374961.EUR","IBB","LU2089984988.USD","LU0882574055.USD","LU2362540622.SGD"],"gpt_icon":1},{"id":"2501817237","title":"Immuneering Price Target Maintained With a $15.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2501817237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501817237?lang=en_us&edition=fundamental","pubTime":"2025-01-08 00:23","pubTimestamp":1736266980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2025 11:23 ET (16:23 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX"],"gpt_icon":0},{"id":"2501207452","title":"Immuneering Shares up 50% After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501207452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501207452?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:31","pubTimestamp":1736260269,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O31HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","IMRX","BK4539","BK4139"],"gpt_icon":0},{"id":"2501743204","title":"Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2501743204","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501743204?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:00","pubTimestamp":1736258404,"startTime":"0","endTime":"0","summary":"Immuneering  said Tuesday that new data from an ongoing phase 2a trial of its lead candidate IMM-1-104 in pancreatic cancer showed better overall response and disease control rates.The updated results for IMM-1-104 combined with modified gemcitabine/nab-paclitaxel showed pancreatic cancer patients achieved an overall response rate of 43% and a disease control rate of 86%, compared with benchmarks of 23% and 48%, respectively, according to Immuneering Chief Executive Ben Zeskind.In another combination arm with modified Folfirinox, all evaluable patients experienced target lesion shrinkage, including a 100% reduction, the company said.As a monotherapy in second-line patients, IMM-1-104 demonstrated a partial response with 67% reduction in target lesions, according to Immuneering.The drug was well-tolerated in both combination and monotherapy arms, the company said, adding it plans to expand the phase 2a trial in 2025 to include three new combination arms.Shares of Immuneering surged past","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","IMRX","BK4139","BK4563"],"gpt_icon":1},{"id":"2501205380","title":"BUZZ-Immuneering soars on positive trial data for pancreatic cancer therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501205380","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501205380?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:53","pubTimestamp":1736254414,"startTime":"0","endTime":"0","summary":"** Shares of therapy developer Immuneering    rise 101.7% to $4.76 premarket   ** Co says its therapy, IMM-1-104, showed an overall response rate of 43% in combination with gemcitabine during a mid-stage trial for patients with pancreatic cancer    ** IMRX will expand the trial to include three combination treatment arms this year in addition to the existing three arms   ** Co says it expects further trial data in Q2 2025   ** Up to last close, stock down 64.8% in the previous 12 months   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"BUZZ-Immuneering soars on positive trial data for pancreatic cancer therapy","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IMRX","BK4139","BK4539"],"gpt_icon":0},{"id":"2501258208","title":"Immuneering Shares up 51.7% Premarket After Positive Mid-Stage Trial Data for Pancreatic Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2501258208","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501258208?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:27","pubTimestamp":1736252853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nFWN3O30NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4539","BK4563","BK4139"],"gpt_icon":0},{"id":"2501720885","title":"BRIEF-Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms Of Ongoing Phase 2A Trial Of IMM-1-104","url":"https://stock-news.laohu8.com/highlight/detail?id=2501720885","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501720885?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:16","pubTimestamp":1736252185,"startTime":"0","endTime":"0","summary":"BRIEF-Immuneering Announces Positive Data Update From Three Pancreatic Cancer Arms Of Ongoing Phase 2A Trial Of IMM-1-104Jan 7 (Reuters) - Immuneering Corp IMRX.O:IMMUNEERING ANNOUNCES POSITIVE DATA U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA6XLNHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2501208801","title":"Immuneering announce data update from Phase 2a trial of IMM-1-104","url":"https://stock-news.laohu8.com/highlight/detail?id=2501208801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501208801?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:11","pubTimestamp":1736251918,"startTime":"0","endTime":"0","summary":"Immuneering (IMRX) announced a positive data update from three pancreatic cancer arms of its ongoing Phase 2a trial of lead program IMM-1-104, as w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immuneering-announce-data-update-from-phase-2a-trial-of-imm-1-104?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immuneering-announce-data-update-from-phase-2a-trial-of-imm-1-104?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4139","BK4539","IMRX"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-02-08","symbol":"IMRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644296400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-09-09","symbol":"IMRX","fiscalQuarterEnding":"2021/06","expectedEps":-1.78,"name":null,"time":"","type":"earning","dateTimestamp":1631160000000,"reportTimeType":"","actualEps":-1.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1734235200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMRX","date":"2025-04-17","current":-0.734953,"percent":0.954292,"low":-38.293729,"twenty":-7.179577,"median":-3.774363,"eighty":-1.086551,"high":-0.544763,"avg":-6.42457,"sd":8.207516,"marketCap":44859065},"quantilePoints":[{"date":"2021-07-30","current":-21.376918,"twenty":-19.48836,"median":-18.229322,"eighty":-11.994698,"marketCap":429009721},{"date":"2021-08-06","current":-34.307584,"twenty":-29.575252,"median":-21.376918,"eighty":-18.229322,"marketCap":688513044},{"date":"2021-08-13","current":-34.781547,"twenty":-35.214189,"median":-30.108764,"eighty":-19.687668,"marketCap":698024914},{"date":"2021-08-20","current":-36.981218,"twenty":-36.655521,"median":-34.307584,"eighty":-21.09011,"marketCap":742169746},{"date":"2021-08-27","current":-32.375276,"twenty":-36.475658,"median":-34.52026,"eighty":-22.529012,"marketCap":649733882},{"date":"2021-09-03","current":-34.404807,"twenty":-36.171837,"median":-34.307584,"eighty":-25.783553,"marketCap":690464197},{"date":"2021-09-10","current":-22.010777,"twenty":-35.957946,"median":-32.776321,"eighty":-24.276106,"marketCap":538214828},{"date":"2021-09-17","current":-30.210454,"twenty":-35.824264,"median":-31.84055,"eighty":-25.184572,"marketCap":738716062},{"date":"2021-09-24","current":-29.160302,"twenty":-35.381899,"median":-31.06967,"eighty":-26.168957,"marketCap":713037379},{"date":"2021-10-01","current":-30.655974,"twenty":-34.823563,"median":-31.016632,"eighty":-26.847844,"marketCap":749610049},{"date":"2021-10-08","current":-29.393669,"twenty":-34.79613,"median":-30.963594,"eighty":-27.123376,"marketCap":718743753},{"date":"2021-10-15","current":-26.370502,"twenty":-34.757241,"median":-30.737841,"eighty":-25.579175,"marketCap":644820271},{"date":"2021-10-22","current":-27.420655,"twenty":-34.594392,"median":-30.019518,"eighty":-25.579175,"marketCap":670498954},{"date":"2021-10-29","current":-28.746605,"twenty":-34.370779,"median":-29.565885,"eighty":-25.859215,"marketCap":702921534},{"date":"2021-11-05","current":-31.674304,"twenty":-34.314876,"median":-29.74372,"eighty":-26.166836,"marketCap":774510591},{"date":"2021-11-12","current":-25.289652,"twenty":-34.283278,"median":-29.565885,"eighty":-26.166836,"marketCap":722963518},{"date":"2021-11-19","current":-22.558333,"twenty":-33.710006,"median":-28.972469,"eighty":-25.187144,"marketCap":644882421},{"date":"2021-11-26","current":-20.453131,"twenty":-32.879093,"median":-28.778428,"eighty":-24.841544,"marketCap":584700312},{"date":"2021-12-03","current":-17.576626,"twenty":-32.696112,"median":-28.497326,"eighty":-23.741458,"marketCap":502468724},{"date":"2021-12-10","current":-19.636457,"twenty":-32.324185,"median":-28.163187,"eighty":-22.296998,"marketCap":561353804},{"date":"2021-12-17","current":-19.309788,"twenty":-32.100427,"median":-27.505516,"eighty":-21.262189,"marketCap":552015201},{"date":"2021-12-23","current":-18.874241,"twenty":-32.022843,"median":-27.430931,"eighty":-20.552946,"marketCap":539564079},{"date":"2021-12-31","current":-14.887633,"twenty":-31.674304,"median":-27.177075,"eighty":-20.40776,"marketCap":425597617},{"date":"2022-01-07","current":-14.243147,"twenty":-31.658256,"median":-26.71902,"eighty":-19.482197,"marketCap":407173478},{"date":"2022-01-14","current":-11.969031,"twenty":-31.51519,"median":-26.42354,"eighty":-19.028489,"marketCap":342162587},{"date":"2022-01-21","current":-11.103578,"twenty":-31.481245,"median":-26.031059,"eighty":-18.640116,"marketCap":317421599},{"date":"2022-01-28","current":-9.206947,"twenty":-31.447301,"median":-25.379254,"eighty":-18.098783,"marketCap":263201990},{"date":"2022-02-04","current":-9.022808,"twenty":-31.303678,"median":-25.09002,"eighty":-15.312994,"marketCap":257937950},{"date":"2022-02-11","current":-8.746599,"twenty":-31.202956,"median":-24.614944,"eighty":-14.27445,"marketCap":250041890},{"date":"2022-02-18","current":-7.669387,"twenty":-31.093007,"median":-23.973184,"eighty":-13.003892,"marketCap":219247257},{"date":"2022-02-25","current":-7.227453,"twenty":-31.006024,"median":-23.297074,"eighty":-12.195522,"marketCap":206613562},{"date":"2022-03-04","current":-6.104206,"twenty":-30.912677,"median":-22.394998,"eighty":-11.324544,"marketCap":174502919},{"date":"2022-03-11","current":-5.104662,"twenty":-30.843317,"median":-21.805179,"eighty":-10.260222,"marketCap":171188670},{"date":"2022-03-18","current":-5.505799,"twenty":-30.766019,"median":-21.218553,"eighty":-9.206947,"marketCap":184641093},{"date":"2022-03-25","current":-5.702435,"twenty":-30.685675,"median":-20.552946,"eighty":-9.004394,"marketCap":191235417},{"date":"2022-04-01","current":-5.851878,"twenty":-30.388662,"median":-20.434983,"eighty":-8.728185,"marketCap":196247104},{"date":"2022-04-08","current":-5.560857,"twenty":-30.095892,"median":-19.881459,"eighty":-7.906926,"marketCap":186487503},{"date":"2022-04-14","current":-5.026008,"twenty":-29.909199,"median":-19.636457,"eighty":-7.155639,"marketCap":168550940},{"date":"2022-04-22","current":-4.632737,"twenty":-29.741472,"median":-19.332473,"eighty":-6.57376,"marketCap":155362291},{"date":"2022-04-29","current":-3.909117,"twenty":-29.600328,"median":-19.028489,"eighty":-6.236786,"marketCap":131095176},{"date":"2022-05-06","current":-3.863096,"twenty":-29.300322,"median":-18.77442,"eighty":-6.076585,"marketCap":129551818},{"date":"2022-05-13","current":-3.301241,"twenty":-29.085169,"median":-18.248113,"eighty":-5.773224,"marketCap":132718053},{"date":"2022-05-20","current":-2.868076,"twenty":-28.958498,"median":-17.902974,"eighty":-5.560857,"marketCap":115303756},{"date":"2022-05-27","current":-3.032154,"twenty":-28.873896,"median":-15.642603,"eighty":-5.43973,"marketCap":121900081},{"date":"2022-06-03","current":-3.117474,"twenty":-28.772063,"median":-15.136221,"eighty":-5.357929,"marketCap":125330170},{"date":"2022-06-10","current":-3.248736,"twenty":-28.702053,"median":-14.560786,"eighty":-5.169159,"marketCap":130607230},{"date":"2022-06-17","current":-3.019028,"twenty":-28.513237,"median":-14.243147,"eighty":-5.057469,"marketCap":121372375},{"date":"2022-06-24","current":-2.966523,"twenty":-28.470807,"median":-13.018623,"eighty":-4.797911,"marketCap":119261551},{"date":"2022-07-01","current":-3.281552,"twenty":-28.322301,"median":-12.535258,"eighty":-4.516125,"marketCap":131926495},{"date":"2022-07-08","current":-4.77794,"twenty":-28.19501,"median":-11.72965,"eighty":-4.342773,"marketCap":192084976},{"date":"2022-07-15","current":-4.764813,"twenty":-27.798285,"median":-11.342958,"eighty":-4.376588,"marketCap":191557270},{"date":"2022-07-22","current":-4.679493,"twenty":-27.596741,"median":-11.177233,"eighty":-4.47804,"marketCap":188127181},{"date":"2022-07-29","current":-4.279144,"twenty":-27.467328,"median":-9.768571,"eighty":-4.342843,"marketCap":172032149},{"date":"2022-08-05","current":-4.200386,"twenty":-27.441339,"median":-9.354258,"eighty":-4.248161,"marketCap":168865913},{"date":"2022-08-12","current":-3.583967,"twenty":-27.424765,"median":-9.206947,"eighty":-4.220076,"marketCap":156770256},{"date":"2022-08-19","current":-4.036488,"twenty":-27.284877,"median":-8.99979,"eighty":-4.217662,"marketCap":176564480},{"date":"2022-08-26","current":-3.638269,"twenty":-27.191847,"median":-8.820255,"eighty":-4.112624,"marketCap":159145562},{"date":"2022-09-02","current":-4.489009,"twenty":-26.964607,"median":-8.663737,"eighty":-4.062597,"marketCap":196358704},{"date":"2022-09-09","current":-5.351815,"twenty":-26.847844,"median":-8.102113,"eighty":-4.089364,"marketCap":234099692},{"date":"2022-09-16","current":-7.409278,"twenty":-26.701741,"median":-7.540489,"eighty":-4.110182,"marketCap":324097431},{"date":"2022-09-23","current":-6.184454,"twenty":-26.518292,"median":-7.478664,"eighty":-4.129108,"marketCap":270521064},{"date":"2022-09-30","current":-8.640135,"twenty":-26.430952,"median":-7.511849,"eighty":-4.171405,"marketCap":377937721},{"date":"2022-10-07","current":-7.753194,"twenty":-26.391717,"median":-7.604938,"eighty":-4.197576,"marketCap":339141042},{"date":"2022-10-14","current":-7.759227,"twenty":-26.166836,"median":-7.710958,"eighty":-4.204957,"marketCap":339404965},{"date":"2022-10-21","current":-7.825597,"twenty":-25.859215,"median":-7.75621,"eighty":-4.215247,"marketCap":342308118},{"date":"2022-10-28","current":-8.145379,"twenty":-25.579175,"median":-7.831631,"eighty":-4.220076,"marketCap":356296036},{"date":"2022-11-04","current":-6.226689,"twenty":-25.361334,"median":-7.837664,"eighty":-4.222148,"marketCap":272368525},{"date":"2022-11-11","current":-4.159708,"twenty":-25.187144,"median":-7.759227,"eighty":-4.222148,"marketCap":199883821},{"date":"2022-11-18","current":-3.846494,"twenty":-25.101534,"median":-7.732076,"eighty":-4.197576,"marketCap":184833124},{"date":"2022-11-25","current":-3.610209,"twenty":-25.039205,"median":-7.656988,"eighty":-4.124428,"marketCap":173479089},{"date":"2022-12-02","current":-3.25853,"twenty":-24.902263,"median":-7.535984,"eighty":-4.049542,"marketCap":156580060},{"date":"2022-12-09","current":-2.846405,"twenty":-24.654192,"median":-7.415311,"eighty":-3.946191,"marketCap":136776511},{"date":"2022-12-16","current":-2.302401,"twenty":-24.266189,"median":-7.240336,"eighty":-3.838309,"marketCap":110635827},{"date":"2022-12-23","current":-2.401311,"twenty":-24.011725,"median":-7.167608,"eighty":-3.788803,"marketCap":115388678},{"date":"2022-12-30","current":-2.665071,"twenty":-23.915253,"median":-6.893039,"eighty":-3.65307,"marketCap":128062950},{"date":"2023-01-06","current":-2.165026,"twenty":-23.683527,"median":-6.748692,"eighty":-3.620168,"marketCap":104034644},{"date":"2023-01-13","current":-2.434281,"twenty":-23.297074,"median":-6.444863,"eighty":-3.571744,"marketCap":116972962},{"date":"2023-01-20","current":-2.384826,"twenty":-23.091187,"median":-6.389597,"eighty":-3.539873,"marketCap":114596536},{"date":"2023-01-27","current":-2.445271,"twenty":-22.654609,"median":-6.277203,"eighty":-3.410189,"marketCap":117501057},{"date":"2023-02-03","current":-2.181511,"twenty":-22.296998,"median":-6.214689,"eighty":-3.365467,"marketCap":104826786},{"date":"2023-02-10","current":-2.077107,"twenty":-22.054954,"median":-6.163676,"eighty":-3.32093,"marketCap":99809886},{"date":"2023-02-17","current":-2.522201,"twenty":-21.846299,"median":-6.058171,"eighty":-3.281552,"marketCap":121197719},{"date":"2023-02-24","current":-2.577151,"twenty":-21.548222,"median":-5.985345,"eighty":-3.232985,"marketCap":123838193},{"date":"2023-03-03","current":-2.79695,"twenty":-21.290871,"median":-5.847945,"eighty":-3.116748,"marketCap":134400085},{"date":"2023-03-10","current":-3.940801,"twenty":-21.215562,"median":-5.7103,"eighty":-3.10326,"marketCap":199063900},{"date":"2023-03-17","current":-4.223408,"twenty":-20.877378,"median":-5.560857,"eighty":-3.116748,"marketCap":213339399},{"date":"2023-03-24","current":-5.427105,"twenty":-20.595727,"median":-5.505799,"eighty":-3.117474,"marketCap":274142450},{"date":"2023-03-31","current":-5.081696,"twenty":-20.542057,"median":-5.445473,"eighty":-3.164729,"marketCap":256694618},{"date":"2023-04-06","current":-4.375178,"twenty":-20.502131,"median":-5.427125,"eighty":-3.201482,"marketCap":221005871},{"date":"2023-04-14","current":-6.463332,"twenty":-20.438612,"median":-5.432339,"eighty":-3.225109,"marketCap":326485946},{"date":"2023-04-21","current":-6.832312,"twenty":-20.413204,"median":-5.498193,"eighty":-3.252654,"marketCap":345124456},{"date":"2023-04-28","current":-6.132304,"twenty":-20.19724,"median":-5.560857,"eighty":-3.267739,"marketCap":309764542},{"date":"2023-05-05","current":-4.649577,"twenty":-19.866941,"median":-5.533328,"eighty":-3.281552,"marketCap":234866707},{"date":"2023-05-11","current":-4.111377,"twenty":-19.803422,"median":-5.498193,"eighty":-3.28549,"marketCap":210590323},{"date":"2023-05-18","current":-4.945072,"twenty":-19.678198,"median":-5.458607,"eighty":-3.297303,"marketCap":253293360},{"date":"2023-05-26","current":-3.72879,"twenty":-19.513049,"median":-5.429742,"eighty":-3.311742,"marketCap":190993723},{"date":"2023-06-02","current":-5.379051,"twenty":-19.431382,"median":-5.427105,"eighty":-3.316992,"marketCap":275522339},{"date":"2023-06-07","current":-5.281977,"twenty":-19.380567,"median":-5.411414,"eighty":-3.319617,"marketCap":270550068},{"date":"2023-06-15","current":-5.321949,"twenty":-19.337011,"median":-5.419259,"eighty":-3.32093,"marketCap":272597473},{"date":"2023-06-23","current":-6.446867,"twenty":-19.309788,"median":-5.427145,"eighty":-3.32093,"marketCap":330217326},{"date":"2023-06-30","current":-5.470415,"twenty":-19.204528,"median":-5.432339,"eighty":-3.331431,"marketCap":280202124},{"date":"2023-07-07","current":-5.658853,"twenty":-19.043008,"median":-5.458607,"eighty":-3.349234,"marketCap":289854180},{"date":"2023-07-14","current":-5.413313,"twenty":-19.015785,"median":-5.464511,"eighty":-3.358014,"marketCap":277277258},{"date":"2023-07-21","current":-5.83016,"twenty":-18.946824,"median":-5.498966,"eighty":-3.361598,"marketCap":298628777},{"date":"2023-07-28","current":-5.35621,"twenty":-18.834312,"median":-5.502382,"eighty":-3.366756,"marketCap":274352393},{"date":"2023-08-04","current":-5.856075,"twenty":-18.640116,"median":-5.538938,"eighty":-3.368463,"marketCap":299956153},{"date":"2023-08-11","current":-5.640407,"twenty":-18.451374,"median":-5.556069,"eighty":-3.380171,"marketCap":292640150},{"date":"2023-08-18","current":-4.969198,"twenty":-18.244355,"median":-5.538938,"eighty":-3.402313,"marketCap":257815972},{"date":"2023-08-25","current":-5.454273,"twenty":-18.229322,"median":-5.536059,"eighty":-3.424628,"marketCap":282983025},{"date":"2023-09-01","current":-5.082007,"twenty":-18.098783,"median":-5.505799,"eighty":-3.473171,"marketCap":263668775},{"date":"2023-09-08","current":-4.732301,"twenty":-17.576626,"median":-5.490588,"eighty":-3.478329,"marketCap":245525085},{"date":"2023-09-15","current":-4.320552,"twenty":-16.848713,"median":-5.45644,"eighty":-3.500309,"marketCap":224162354},{"date":"2023-09-22","current":-4.360034,"twenty":-15.642603,"median":-5.442993,"eighty":-3.543057,"marketCap":226210835},{"date":"2023-09-29","current":-4.416439,"twenty":-15.41427,"median":-5.427145,"eighty":-3.548423,"marketCap":229137237},{"date":"2023-10-06","current":-4.207743,"twenty":-15.180414,"median":-5.412363,"eighty":-3.550464,"marketCap":218309551},{"date":"2023-10-13","current":-3.522434,"twenty":-14.937351,"median":-5.379051,"eighty":-3.550464,"marketCap":182753773},{"date":"2023-10-20","current":-3.384244,"twenty":-14.860012,"median":-5.35907,"eighty":-3.513584,"marketCap":175584090},{"date":"2023-10-27","current":-3.023258,"twenty":-14.841598,"median":-5.356356,"eighty":-3.478329,"marketCap":156855120},{"date":"2023-11-03","current":-3.384244,"twenty":-14.279974,"median":-5.34622,"eighty":-3.412814,"marketCap":175584090},{"date":"2023-11-10","current":-2.947163,"twenty":-14.252354,"median":-5.321949,"eighty":-3.384244,"marketCap":152172878},{"date":"2023-11-17","current":-2.913665,"twenty":-14.243147,"median":-5.300305,"eighty":-3.384244,"marketCap":150443281},{"date":"2023-11-24","current":-4.364829,"twenty":-13.705461,"median":-5.294869,"eighty":-3.382454,"marketCap":225372231},{"date":"2023-12-01","current":-3.718608,"twenty":-13.129106,"median":-5.237177,"eighty":-3.384244,"marketCap":192005433},{"date":"2023-12-08","current":-4.631254,"twenty":-12.974429,"median":-5.212533,"eighty":-3.384244,"marketCap":239128718},{"date":"2023-12-15","current":-4.381835,"twenty":-12.812387,"median":-5.168731,"eighty":-3.384244,"marketCap":226250305},{"date":"2023-12-22","current":-3.956689,"twenty":-12.49751,"median":-5.15972,"eighty":-3.384244,"marketCap":204298464},{"date":"2023-12-29","current":-4.421515,"twenty":-12.271019,"median":-5.151886,"eighty":-3.384244,"marketCap":228299143},{"date":"2024-01-05","current":-3.837648,"twenty":-12.044528,"median":-5.118331,"eighty":-3.384244,"marketCap":198151949},{"date":"2024-01-12","current":-3.531543,"twenty":-11.586022,"median":-5.092178,"eighty":-3.384244,"marketCap":182346623},{"date":"2024-01-19","current":-3.293462,"twenty":-11.446076,"median":-5.084468,"eighty":-3.384244,"marketCap":170053593},{"date":"2024-01-26","current":-3.514538,"twenty":-11.37242,"median":-5.081696,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-02-02","current":-3.256616,"twenty":-11.315338,"median":-5.051704,"eighty":-3.384244,"marketCap":168151100},{"date":"2024-02-09","current":-3.452183,"twenty":-11.269303,"median":-5.026008,"eighty":-3.380663,"marketCap":178248946},{"date":"2024-02-16","current":-3.797968,"twenty":-11.162502,"median":-4.979499,"eighty":-3.384244,"marketCap":196103110},{"date":"2024-02-23","current":-3.639247,"twenty":-10.897342,"median":-4.964988,"eighty":-3.384244,"marketCap":187907756},{"date":"2024-03-01","current":-3.514538,"twenty":-10.260222,"median":-4.924075,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-03-08","current":-3.658244,"twenty":-9.709646,"median":-4.89778,"eighty":-3.384244,"marketCap":195612256},{"date":"2024-03-15","current":-1.58816,"twenty":-9.573383,"median":-4.876386,"eighty":-3.370913,"marketCap":84921488},{"date":"2024-03-22","current":-1.495061,"twenty":-9.38372,"median":-4.839647,"eighty":-3.363712,"marketCap":79943332},{"date":"2024-03-28","current":-1.330768,"twenty":-9.206947,"median":-4.791108,"eighty":-3.351606,"marketCap":71158350},{"date":"2024-04-05","current":-1.286957,"twenty":-9.206947,"median":-4.774314,"eighty":-3.322939,"marketCap":68815689},{"date":"2024-04-12","current":-1.139094,"twenty":-9.203264,"median":-4.742734,"eighty":-3.314805,"marketCap":60909205},{"date":"2024-04-19","current":-0.969325,"twenty":-9.160911,"median":-4.686056,"eighty":-3.281552,"marketCap":51831391},{"date":"2024-04-26","current":-0.793024,"twenty":-9.045594,"median":-4.679711,"eighty":-3.256999,"marketCap":42404297},{"date":"2024-05-03","current":-0.865117,"twenty":-9.02559,"median":-4.67293,"eighty":-3.222326,"marketCap":46259233},{"date":"2024-05-10","current":-0.853881,"twenty":-9.013601,"median":-4.631996,"eighty":-3.197538,"marketCap":46259233},{"date":"2024-05-17","current":-0.842934,"twenty":-8.960201,"median":-4.600736,"eighty":-3.119794,"marketCap":45666166},{"date":"2024-05-24","current":-0.777251,"twenty":-8.87918,"median":-4.556776,"eighty":-3.079409,"marketCap":42107764},{"date":"2024-05-31","current":-0.755356,"twenty":-8.820255,"median":-4.537707,"eighty":-3.038717,"marketCap":40921629},{"date":"2024-06-07","current":-0.771777,"twenty":-8.746599,"median":-4.512325,"eighty":-2.993026,"marketCap":41811230},{"date":"2024-06-14","current":-0.925038,"twenty":-8.709772,"median":-4.502289,"eighty":-2.980329,"marketCap":50114169},{"date":"2024-06-21","current":-0.771777,"twenty":-8.664307,"median":-4.495207,"eighty":-2.939832,"marketCap":41811230},{"date":"2024-06-28","current":-0.782724,"twenty":-8.640135,"median":-4.489009,"eighty":-2.920581,"marketCap":42404297},{"date":"2024-07-05","current":-0.618516,"twenty":-8.629554,"median":-4.472533,"eighty":-2.895554,"marketCap":33508291},{"date":"2024-07-12","current":-0.717041,"twenty":-8.545779,"median":-4.46206,"eighty":-2.873326,"marketCap":38845895},{"date":"2024-07-15","current":-0.678726,"twenty":-8.525496,"median":-4.461562,"eighty":-2.868076,"marketCap":36770160},{"date":"2024-08-02","current":-0.738935,"twenty":-8.503775,"median":-4.455922,"eighty":-2.850739,"marketCap":40032029},{"date":"2024-08-09","current":-0.592364,"twenty":-8.404824,"median":-4.42544,"eighty":-2.804643,"marketCap":33211757},{"date":"2024-08-16","current":-0.571208,"twenty":-8.326387,"median":-4.418977,"eighty":-2.748595,"marketCap":32025623},{"date":"2024-08-23","current":-0.555341,"twenty":-8.193648,"median":-4.410178,"eighty":-2.718038,"marketCap":31136022},{"date":"2024-08-30","current":-0.61352,"twenty":-8.144091,"median":-4.381439,"eighty":-2.669467,"marketCap":34397891},{"date":"2024-09-06","current":-0.629387,"twenty":-8.138941,"median":-4.377791,"eighty":-2.637596,"marketCap":35287492},{"date":"2024-09-13","current":-0.756322,"twenty":-8.109177,"median":-4.364829,"eighty":-2.553047,"marketCap":42404297},{"date":"2024-09-20","current":-1.27993,"twenty":-8.065285,"median":-4.359401,"eighty":-2.472746,"marketCap":71761119},{"date":"2024-09-27","current":-1.38042,"twenty":-8.006605,"median":-4.328077,"eighty":-2.428786,"marketCap":77395256},{"date":"2024-10-04","current":-1.253485,"twenty":-7.946269,"median":-4.308243,"eighty":-2.401311,"marketCap":70278451},{"date":"2024-10-11","current":-1.17415,"twenty":-7.940236,"median":-4.278792,"eighty":-2.379331,"marketCap":65830448},{"date":"2024-10-18","current":-1.105394,"twenty":-7.928168,"median":-4.243224,"eighty":-2.324381,"marketCap":61975511},{"date":"2024-10-25","current":-1.137127,"twenty":-7.922135,"median":-4.223408,"eighty":-2.296906,"marketCap":63754713},{"date":"2024-10-31","current":-1.015481,"twenty":-7.922135,"median":-4.220076,"eighty":-2.247451,"marketCap":56934441},{"date":"2024-11-08","current":-1.02077,"twenty":-7.917308,"median":-4.210694,"eighty":-2.203491,"marketCap":57230975},{"date":"2024-11-15","current":-0.990682,"twenty":-7.877486,"median":-4.200386,"eighty":-2.163927,"marketCap":57527508},{"date":"2024-11-22","current":-1.077494,"twenty":-7.863006,"median":-4.18227,"eighty":-2.124364,"marketCap":62568579},{"date":"2024-11-29","current":-1.117565,"twenty":-7.850938,"median":-4.154565,"eighty":-1.653919,"marketCap":64895436},{"date":"2024-12-06","current":-1.144301,"twenty":-7.836458,"median":-4.134218,"eighty":-1.535604,"marketCap":66447958},{"date":"2024-12-13","current":-1.053398,"twenty":-7.828011,"median":-4.114285,"eighty":-1.501633,"marketCap":61169382},{"date":"2024-12-20","current":-0.983885,"twenty":-7.785775,"median":-4.110253,"eighty":-1.404904,"marketCap":57132824},{"date":"2024-12-27","current":-1.16569,"twenty":-7.756814,"median":-4.094935,"eighty":-1.382465,"marketCap":67689976},{"date":"2025-01-03","current":-1.181731,"twenty":-7.753194,"median":-4.069124,"eighty":-1.319715,"marketCap":68621490},{"date":"2025-01-10","current":-1.06944,"twenty":-7.753194,"median":-4.066404,"eighty":-1.306374,"marketCap":62100896},{"date":"2025-01-17","current":-1.048051,"twenty":-7.710958,"median":-4.027437,"eighty":-1.27993,"marketCap":60858878},{"date":"2025-01-24","current":-1.149648,"twenty":-7.677701,"median":-4.004689,"eighty":-1.260248,"marketCap":66758463},{"date":"2025-01-31","current":-1.037357,"twenty":-7.649549,"median":-3.985032,"eighty":-1.226534,"marketCap":60237869},{"date":"2025-02-07","current":-1.064093,"twenty":-7.561309,"median":-3.979207,"eighty":-1.20312,"marketCap":61790391},{"date":"2025-02-14","current":-0.994579,"twenty":-7.536885,"median":-3.968026,"eighty":-1.196414,"marketCap":57753833},{"date":"2025-02-21","current":-0.914371,"twenty":-7.521503,"median":-3.9572,"eighty":-1.17549,"marketCap":53096266},{"date":"2025-02-28","current":-0.892982,"twenty":-7.492892,"median":-3.932768,"eighty":-1.164843,"marketCap":51854248},{"date":"2025-03-07","current":-0.807427,"twenty":-7.444909,"median":-3.863096,"eighty":-1.158283,"marketCap":46886176},{"date":"2025-03-14","current":-0.823469,"twenty":-7.414105,"median":-3.842071,"eighty":-1.144301,"marketCap":47817689},{"date":"2025-03-21","current":-0.882288,"twenty":-7.351355,"median":-3.83198,"eighty":-1.141087,"marketCap":51233239},{"date":"2025-03-28","current":-0.976018,"twenty":-7.269298,"median":-3.811457,"eighty":-1.130407,"marketCap":59572838},{"date":"2025-04-04","current":-0.887824,"twenty":-7.236716,"median":-3.801177,"eighty":-1.115426,"marketCap":54189750},{"date":"2025-04-11","current":-0.729074,"twenty":-7.230193,"median":-3.789261,"eighty":-1.103846,"marketCap":44500192},{"date":"2025-04-17","current":-0.734953,"twenty":-7.179577,"median":-3.774363,"eighty":-1.086551,"marketCap":44859065}],"updateTime":1745291495418}}}